Israel's Teva reaches potential $4.25 bn US opioid settlement
INSUBCONTINENT EXCLUSIVE:
WASHINGTON - Israeli generic drug maker Teva has reached an agreement in principle to pay $4.25 billion over 13 years to settle a series of
court cases over its role in the US opioid epidemic.
